Skip to main content
. 2019 Apr 16;69(7):1112–1119. doi: 10.1093/cid/ciy1063

Table 1.

Characteristics of Subjects That Participated in Both Direct-skin and Membrane Feeding

Ivermectin 600 mcg/kg/day for 3 Days
(n = 22)
Ivermectin 300 mcg/kg/day for 3 Days
(n = 24)
Placebo
(n = 23)
Age, years 27.3 (7.4) 25.5 (7.5) 26.0 (5.0)
Sex
 Male 13 (59%) 16 (67%) 14 (61%)
 Female 9 (41%) 8 (33%) 9 (39%)
Body mass index, kg/m2 22.9 (3.4) 21.5 (3.0) 21.6 (2.6)

Data are shown as n (%) or mean (standard deviation). Baseline characteristics of subjects that participated in both direct skin and membrane feeding (n = 69) were similar to those of the other trial participants that did not (n = 72) [6].